Water Island Capital’s Clearside Biomedical CLSD Stock Holding History

Water Island Capital’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,500	Closed	-$71.8K	–	66
2023 Q3	$71.8K	Buy	5,500 +667	+14%	+$10.1K	0.01%	77
2023 Q2	$81.2K	Buy	4,833 +500	+12%	+$8.61K	0.01%	70
2023 Q1	$67.6K	Buy	4,333 +1,200	+38%	+$23.3K	0.01%	73
2022 Q4	$52.6K	Buy	+3,133	New	+$56.4K	﹤0.01%	83

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Water Island Capital's CLSD Position: Q4 2023 in Review

Water Island Capital sold out of Clearside Biomedical (CLSD) in Q4 2023, closing a stake of 5,500 shares — an estimated $71.8K sold.

Water Island Capital first reported a position in CLSD in Q4 2022 and held it in 4 quarters. The position peaked at $81.2K in Q2 2023. 46 funds tracked by Wall St. Rank hold CLSD as of Q4 2023.

Water Island Capital reported no remaining Clearside Biomedical position as of Q4 2023 after selling out during the quarter.
Water Island Capital sold 5,500 Clearside Biomedical shares in Q4 2023, an estimated $71.8K.
Water Island Capital first reported a position in Clearside Biomedical in Q4 2022 and held it in 4 quarters.
Water Island Capital's Clearside Biomedical position peaked at $81.2K in Q2 2023.
46 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2023.

Based on Water Island Capital's 13F filing for Q4 2023, filed 13 Feb 2024.